Cargando…
The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database
OBJECTIVE: The coronavirus disease 2019 pandemic has been resulting in increased hospital occupancy rates. Rheumatic patients cannot still reach to hospitals, or they hesitate about going to a hospital even they are able to reach. We aimed to show the effect of the first wave of coronavirus disease...
Autores principales: | Alpay Kanıtez, Nilüfer, Kiraz, Sedat, Dalkılıç, Ediz, Kimyon, Gezmiş, Mercan, Rıdvan, Karadağ, Ömer, Bes, Cemal, Kılıç, Levent, Akar, Servet, Ateş, Aşkın, Emmungil, Hakan, Ertenli, İhsan, Pehlivan, Yavuz, Nihan Coşkun, Belkıs, Yağız, Burcu, Ersözlü, Duygu, Gönüllü, Emel, Çınar, Muhammet, Kaşifoğlu, Timuçin, Serdar Koca, Süleyman, Karasu, Uğur, Küçükşahin, Orhan, Kalyoncu, Umut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mesut Onat
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089133/ https://www.ncbi.nlm.nih.gov/pubmed/36650959 http://dx.doi.org/10.5152/eurjrheum.2022.21153 |
Ejemplares similares
-
Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure database
por: Ersözlü, Emine Duygu, et al.
Publicado: (2022) -
Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic
por: KALYONCU, Umut, et al.
Publicado: (2021) -
Attitudes of patients with a rheumatic disease on drug use in the COVID-19 pandemic
por: Coskun, Belkıs Nihan, et al.
Publicado: (2021) -
Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?
por: Coşkun, Belkıs Nihan, et al.
Publicado: (2022) -
The effects of COVID-19 infection on the mortality of patients receiving rituximab therapy
por: Ekin, Ali, et al.
Publicado: (2022)